Issue: February 2019
February 07, 2019
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
CONSERVE
Issue: February 2019
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Researchers evaluated the safety, efficacy and cost efficiency of coronary CTA for stable patients without known CAD and a class II indication for non-emergent invasive coronary angiography (ICA).